Companies Cryptocurrencies
NextCure Inc
NextCure Inc
Exchange: NasdaqGS
IPO Date: 09/05/2019
CEO: Mr. Michael Richman
Biotechnology Healthcare 🔗
  • NXTC
  • 7.05
  • 194661792
    market cap
  • 0.16000032
If you bought

shares of NextCure Inc (NXTC) on
You would have made
Old Price $12 Current Price $12

NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. The company is headquartered in Beltsville, Maryland and currently employs 44 full-time employees. The firm uses its functional integrated nextcure discovery in immune oncology (FIND-IO) technology to functional screening approaches for the identification of targets from multiple therapeutic areas, including autoimmunity and neurology, enabling immunomedicine to treat unmet medical needs. Its product pipelines include NC318, a immunotherapeutic against a immunomodulatory target found on a restricted set of myeloid and tumor cells, and NC410, a immunomedicine designed to block an immune regulator expressed on T cells and suppressive antigen-presenting cell populations, including dendritic cell subpopulations.

Address: 9000 Virginia Manor Rd Ste 200 Beltsville MARYLAND 20705

Stay updated.